Fierce Pharma

MARCH 1, 2024

Moderna is laying off employees within its manufacturing unit, with the move tied to a resizing of its COVID production work. | Moderna is laying off some employees within its manufacturing unit after shaving COVID production costs. The company previously disclosed plans to rightsize its COVID vaccine production footprint.

Vaccines 129

Vaccines 129

European Pharmaceutical Review

APRIL 15, 2024

billion to expand the planned FUJIFILM Diosynth Biotechnologies manufacturing facility in Holly Springs, North Carolina, US. The expansion means identical large-scale production facilities can be built in US and Europe to support integration drug manufacturing production “regardless of location”, FUJIFILM explained.

89

89

Drug Topics

MAY 31, 2023

The frequency of drug manufacturer coupon utilization is associated with more market competition—but not patients’ out-of-pocket costs.

187

187

Fierce Pharma

APRIL 18, 2024

History is coming full circle as induced pluripotent stem (iPS) cell-derived cell therapy maker Shinobi Therapeutics links up with Panasonic and Japan’s Kyoto University, where the first mouse iPS | Shinobi Therapeutics has entered an accord with electronics powerhouse Panasonic and Kyoto University in a bid to develop a new closed-system manufacturing (..)

119

119

Pharmafile

APRIL 24, 2024

Eli Lilly and Nexus Pharmaceuticals have announced that they have entered into a definitive agreement for Eli Lilly to acquire a manufacturing facility from Nexus. The post Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals appeared first on Pharmafile.

59

59

European Pharmaceutical Review

MARCH 14, 2024

Overall, the goal of expanded facility is to strengthen [SK biosciences] manufacturing capabilities for global supply [of the pneumococcal conjugate vaccine candidate GBP410]” SK bioscience has announced its manufacturing plant L HOUSE, in Andong, Gyeongsangbuk-do, South Korea, is set to have a facility expansion.

Vaccines 89

Vaccines 89

Fierce Pharma

APRIL 3, 2024

Demand fluctuations have spurred Thermo Fisher Scientific to downsize at the plasmid DNA manufacturing facility the company opened a little less than three years ago, putting jobs on the chopping b | Demand fluctuations have spurred Thermo Fisher Scientific to downsize at the plasmid DNA manufacturing facility the company opened a little less than (..)

105

105

Fierce Pharma

APRIL 9, 2024

Though gene therapy manufacturing specialist Ascend Advanced Therapies just launched a little more than a year ago, the CDMO is already on the hunt to expand. Ascend, which bills itself as a “total solutions gene therapy development partner,” has picked up the manufacturing team and site of Beacon Therapeutics in Alachua, Florida.

114

114

European Pharmaceutical Review

FEBRUARY 16, 2024

Researchers have highlighted the potential of end-to-end continuous manufacture with column-free capture alternatives. they are a “prime” test option for continuous manufacturing. Since monoclonal antibodies (mAbs) represent the fastest growing biopharmaceutical market segment, according to Neves et al. Neves et al. Neves et al.

85

85

European Pharmaceutical Review

FEBRUARY 5, 2024

Novo Nordisk is set to acquire three fill-finish manufacturing sites from Novo Holdings A/S (Novo Holdings) for $11 billion. This agreement is part of a transaction in which Novo Holdings agreed to acquire the contract development and manufacturing organisation (CDMO) Catalent.

96

96

Outsourcing Pharma

APRIL 12, 2024

In the fast-paced domain of pharmaceutical contract development and manufacturing organizations (CDMOs), Selkirk Pharma believes it stands out as a beacon of innovation and reliability.

77

77

European Pharmaceutical Review

NOVEMBER 14, 2023

The Association of the British Pharmaceutical Industry (ABPI) has drawn attention to a new report , which has emphasised the importance of UK advanced manufacturing requiring a long-term strategy to ensure its continued success. Article: Are we globally prepared for the next pandemic?

99

99

European Pharmaceutical Review

FEBRUARY 2, 2024

Orano Med (a subsidiary of the Orano Group), has begun to build a new manufacturing site for targeted alpha therapies (TAT) for oncology indications. So construction of the new radioligand therapy manufacturing site in France is a major step towards making these promising new treatments available to cancer patients with high unmet needs.

91

91

Drug Topics

NOVEMBER 16, 2022

Discount cards and manufacturer coupons can cost pharmacies in the long run.

220

220

Fierce Healthcare

MARCH 4, 2024

Mark Cuban Cost Plus Drugs Company will begin manufacturing its own generic medications this week, starting with sterile injectables, founder and CEO Dr. | Mark Cuban Cost Plus Drugs Company will begin manufacturing its own generic medications this week, starting with sterile injectables, founder and CEO Dr. Alex Oshmyansky said Monday during a White (..)

132

132

European Pharmaceutical Review

SEPTEMBER 12, 2023

A new state-of-the-art manufacturing facility for microbiome ecosystem therapies has now completed construction. With the manufacturing infrastructure finished, the transfer of MaaT Pharma’s Production and Development teams to the new site has also taken place.

95

95

pharmaphorum

JANUARY 9, 2024

Manufacturing problems have scuppered Astellas’ chances of approval in the US this month for zolbetuximab, currently leading the field among Claudin 18.2-targeted targeted drug candidates for cancer.

FDA 110

FDA 110

pharmaphorum

FEBRUARY 8, 2024

BioNTech has taken a $200 million stake in Autolus in a private placement that will allow it to tap into the UK company’s manufacturing capacity for CAR-T therapies

109

109

European Pharmaceutical Review

SEPTEMBER 28, 2023

There has been a steady stream of developments in the vaccine manufacturing space throughout 2023. A notable milestone was Moderna’s announcement in April that it had, following finalisation of a ten-year strategic partnership with the UK Government, commenced construction of its mRNA vaccine manufacturing technology centre.

Vaccines 90

Vaccines 90

European Pharmaceutical Review

MARCH 11, 2024

The manufacturer Olympus Corporation has announced the rescission of an earlier acquisition deal due to reported data integrity issues of medical device products from Taewoong Medical Co., Taewoong Medical focuses on the R&D and manufacturing of non-vascular metallic stents for gastrointestinal (GI) diseases.

88

88

Fierce Healthcare

NOVEMBER 21, 2023

Legacy Medical Consultants, a wound care manufacturer, is under fire for its business practices that critics say are another example of companies in the industry exploiting the Medicare system. |

116

116

European Pharmaceutical Review

APRIL 11, 2024

A current good manufacturing practice (cGMP) oligonucleotide manufacturing facility is set to be built Berlin. It will utilise AKB’s oligo manufacturing equipment, covering all upstream and downstream manufacturing unit operations from synthesis to concentration, the parties confirmed.

52

52

European Pharmaceutical Review

JANUARY 12, 2024

New technologies at the facility will support the increased manufacturing capacity, the company stated on X. The post Boehringer plans €120m European manufacturing expansion appeared first on European Pharmaceutical Review. The expansion will boost exports of medicines from Greece to the US market.

Pharmaceutical Companies 100

Pharmaceutical Companies Pharmaceutical Companies 100

European Pharmaceutical Review

NOVEMBER 23, 2023

Following the UK government’s recent announcement of a £520 million funding boost for UK manufacturing, a new Oligonucleotide Manufacturing Innovation Centre of Excellence in Scotland will develop innovative and sustainable techniques for these medicines. There is a massive gap in the supply and demand for this innovative technology.

Packaging 90

Packaging 90

European Pharmaceutical Review

APRIL 3, 2024

Research by Roots Analysis predicts the pharmaceutical contract manufacturing market will value $140 billion by 2030. The report noted that there has been “considerable” merger and acquisition activity in recent years within the pharmaceutical contract manufacturing market. percent between 2022-2030.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Compounding 52

STAT

APRIL 9, 2024

Philips will be required to overhaul its manufacturing and quality control systems and hire independent experts to vet the changes, according to a court order announced by the U.S. WASHINGTON — The company responsible for a global recall of sleep apnea machines  will be barred from resuming production at U.S.

FDA 111

FDA 111

BioPharm

MARCH 25, 2024

site acquisition, Lonza gains one of the largest biologics manufacturing sites for mammalian cell-based therapeutics. With the Vacaville, Calif.,

98

98

Fierce Pharma

FEBRUARY 22, 2024

To get a pulse on Moderna following its “year of transition” in 2023, look no further than the company’s manufacturing operations. | To get a pulse on Moderna following its “year of transition” in 2023, look no further than the company’s manufacturing operations.

Vaccines 105

Vaccines 105

STAT

FEBRUARY 5, 2024

But Monday’s announcement that the parent company of Novo Nordisk, the maker of the weight loss drug Wegovy, plans to buy Catalent , a company to which drugmakers outsource manufacturing, is probably even more important than it seems.

Vaccines 126

Vaccines 126

European Pharmaceutical Review

FEBRUARY 27, 2024

It is the company ’s most advanced manufacturing facility to date. Additionally, in partnership with Columbus State Community College, Amgen declared that it hosting an 18-month manufacturing apprenticeship at the new facility. Amgen has opened a new biomanufacturing plant in Central Ohio, US.

Pharmaceutical Companies 103

Pharmaceutical Companies Pharmaceutical Companies FDA 103

European Pharmaceutical Review

MARCH 7, 2024

On 4 March, ahead of the Spring Budget , the UK Chancellor of the Exchequer, Jeremy Hunt, announced a significant investment package for the UK life sciences and manufacturing sectors. A total of £360 million is set to boost UK manufacturing and R&D. A sum of £7.5 A sum of £7.5

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Packaging Vaccines 98

Roots Analysis

MARCH 26, 2024

However, in order to deal with this situation, the medical agencies came up with the option of advanced technologies, such as continuous manufacturing technology. In fact, drug manufacturers are moving faster than ever to cope up with the drug shortages. Specifically, in the pharmaceutical industry, the standstill days are over.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies FDA 52

European Pharmaceutical Review

NOVEMBER 9, 2023

This programme was developed by the British Standards Institute (BSI) to verify companies that are taking the necessary steps in ensuring responsible antibiotic manufacturing in the global supply chain, helping to lower the spread of AMR.

108

108

European Pharmaceutical Review

FEBRUARY 21, 2024

Based on data from the Confederation of British Industry (CBI)’s latest monthly Industrial Trends Survey on UK manufacturing, expectations for future selling price inflation rose in February, to their strongest since July 2023. However, manufacturers expect output to rise slightly in the quarter to May, according to the data.

74

74

European Pharmaceutical Review

APRIL 8, 2024

A study investigating the trend for existing pharmaceutical companies to outsource to contracted development and manufacturing organisations (CDMOs), analysing the position of companies manufacturing monoclonal antibody drugs (mAbs). Yoshiura et al. Yoshiura et al.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Compounding 52

Fierce Pharma

MARCH 13, 2024

After Takeda’s unsuccessful attempt to sell an Austrian manufacturing and development site, the Japan-based company is calling it quits on much of the operations at the facility.

118

118

European Pharmaceutical Review

DECEMBER 6, 2023

In the interview, conducted at CPHI Barcelona, Krishna Venkatesh, Global Head, Sterile Manufacturing Operations at Dr Reddy’s Laboratories explores industry’s growing focus on achieving end-to-end connectivity, as well as the potential of automation and track and trace solutions. KV : We have seen two specific elements.

Packaging 86

Packaging Vaccines 86